Home
Solutions
Products
Pricing
Resources
Request Demo
Start Free
Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo
StateStorm

Weekly Updates

LegiStorm is constantly adding new information on the people, places and reports in our database. In the past week, LegiStorm added:

  • 376 new people
  • 171 new organizations
  • 408 new photos
  • 1234 job history records for people in our database
  • 653 education records for people in our database
  • 1467 contact addresses, emails and URLs (LinkedIn, Facebook, etc.)
  • 3 new people through the revolving door
  • 109 new policy reports
  • 43 new trips to our privately funded travel database
  • 629 new personal financial disclosures
  • 15148 new press releases
  • 11 new town halls
  • 25 new hearings

Caught Our Eye Rss

» More from Caught Our Eye
» More from our DevBlog

Human Fetal Tissue: Acquisition for Federally Funded Biomedical Research

  Premium   Download PDF Now (8 pages)
Report Type Reports and Testimonies
Report Date Oct. 4, 2000
Report No. GAO-01-65R
Subject
Summary:

This report focuses on the federal involvement in acquiring human fetal tissue for preclinical research. Department of Health and Human Services (HHS) officials reported that the National Institute for Health (NIH) is the only federal agency under the Senate Labor, HHS, and Education Subcommittee's jurisdiction that sponsors research using human fetal tissue. According a GAO survey, 12,116 human fetal tissue samples were acquired during fiscal years 1997 through 1999 for use in NIH-sponsored research. In fiscal year 1999, three fetal tissue suppliers received federal funding. For therapeutic transplantation research, the NIH Revitalization Act requires written statements by the donor, the physician who obtained the tissue, and the researcher receiving the tissue to ensure that the provisions of the law are met. It also requires that all applicable and local laws must be followed. The costs to acquire human fetal tissue were low. Principal investigators reported that quality of tissue and compliance with federal regulations were their primary criteria for choosing a human fetal tissue supplier.

« Return to search Government Accountability Office reports

HomeAbout Us Contact UsPrivacy PolicyTerms of UseJoin Us
© LegiStorm
LegiStorm
2101 L St. NW, Suite 300
Washington, DC 20037
(202) 360-4172 / congress@legistorm.com